CD cobas Analyzer Series: payments to doctors
Payments that named CD cobas Analyzer Series as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Roche Diagnostics Corporation?
Roche Diagnostics Corporation reported the most payments naming CD cobas Analyzer Series. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $153K
- Providers
- 64
- Transactions
- 107
- Average per transaction
- $1,433
The per-transaction average — $1,433 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 64 providers the average total is $2,396, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Roche Diagnostics Corporation | $115,748 | 75.5% |
| Roche Diagnostics Operations, Inc. | $37,605 | 24.5% |
Other products from Roche Diagnostics Corporation
The company that reported the most payments naming CD cobas Analyzer Series also reports against these.
- DIS Navify Software$677,366
- CD cobas Reagents$466,288
- MD cobas Instruments and Reagents$246,551
- CD cobas Automation$191,829
- BENCHMARK SPECIAL STAINS WASH II$141,223
- RS Harmony Test Related Products$123,053
- POC cobas Liat Analyzer, Assays, Controls and Accessories$121,630
- CINtec PLUS Cytology$112,362
- MD Cobas 6800 8800$103,977
- Non Product Specific$95,637